
0:00
30:18
Katie King, co-founder and chief executive of BioOrbit, discusses how her company is building pharmaceutical manufacturing facilities designed to operate in space and why that could fundamentally transform how the production of medicine works.
BioOrbit is a British space tech company that aims to use the irreplicable conditions of outer space to improve the development of drugs that could massively shape how humans treat some of Earth’s most dangerous conditions.
Weitere Episoden von „UKTN | The Podcast“



Verpasse keine Episode von “UKTN | The Podcast” und abonniere ihn in der kostenlosen GetPodcast App.








